MSH Biopharma, Inc.
Records under this name other than patents MSH Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to MSH Biopharma, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,800,291 | Uro-genital condition treatment system Term ended Ended no later than Mar 23, 2020 · USPTO record | Term ended | Ended no later than Mar 23, 2020 | USPTO record |
| US 6,894,028 | Use of KPV tripeptide for dermatological disorders Lapsed on the fee record Ended May 17, 2017 · USPTO record | Lapsed on the fee record | Ended May 17, 2017 | USPTO record |
| US 7,244,710 | Treatment of ophthalmic infections using antimicrobial peptides Lapsed on the fee record Ended Jul 17, 2015 · USPTO record | Lapsed on the fee record | Ended Jul 17, 2015 | USPTO record |
| US 7,232,804 | Use of KPV tripeptide for dermatological disorders Lapsed on the fee record Ended Jun 19, 2015 · USPTO record | Lapsed on the fee record | Ended Jun 19, 2015 | USPTO record |
| US 7,115,574 | System and method for support legacy operating system booting in a legacy-free system Lapsed on the fee record Ended Oct 3, 2014 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2014 | USPTO record |